National medical group appoints two executives

GenesisCare has also committed more than $300 million to upgrade technology and cancer treatment services nationwide.


  • By
  • | 8:07 a.m. June 22, 2021
Courtesy. Dr. Bridget Koontz was named U.S. Chief Medical Officer and Deputy Group CMO at GenesisCare.
Courtesy. Dr. Bridget Koontz was named U.S. Chief Medical Officer and Deputy Group CMO at GenesisCare.
  • Charlotte–Lee–Collier
  • Share

FORT MYERS — Australian cancer treatment giant GenesisCare, which entered the U.S. in late 2019 when it acquired Fort Myers-based 21st Century Oncology, has named two top domestic medical officials.

 

Continue reading your article
with a Business Observer subscription.
What's included:
  • ✓ Unlimited digital access to BusinessObserverFL.com
  • ✓ E-Newspaper app, digital replica of print edition
  • ✓ Mailed print newspaper every Friday (optional)
  • ✓ Newsletter of daily business news

Latest News

Sponsored Content